TP53 and malignant colon neoplasm: In addition, by applying systems biology approaches, a novel mechanism of action is proposed that involves ATF4-P53-NFκB specific gene expression and autophagy stress pathways, which suppress colon cancer cell growth, cell motility, and angiogenesis in vitro and promotes antitumor immunogenic cell death in vivo.